Cargando…

Albendazole-induced liver injury: a case report

We report a case of a 47-year-old male, who was referred to the clinical hepatology services at Pablo Tobón Uribe Hospital for evaluation of a jaundice syndrome. After undergoing several exams, we diagnosed hepatic hydatidosis and the patient was treated with albendazole; however, after five months...

Descripción completa

Detalles Bibliográficos
Autores principales: Ríos, David, Restrepo, Juan C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Universidad del Valle 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002020/
https://www.ncbi.nlm.nih.gov/pubmed/24892458
_version_ 1782313773719093248
author Ríos, David
Restrepo, Juan C
author_facet Ríos, David
Restrepo, Juan C
author_sort Ríos, David
collection PubMed
description We report a case of a 47-year-old male, who was referred to the clinical hepatology services at Pablo Tobón Uribe Hospital for evaluation of a jaundice syndrome. After undergoing several exams, we diagnosed hepatic hydatidosis and the patient was treated with albendazole; however, after five months of uninterrupted treatment the patient again consulted and his liver test showed marked hepatocellular damage. This time, the patient was diagnosed with drug-induced liver injury due to albendazole, based on information from the clinical record, history of drug consumption, clinical and laboratory tests improved after discontinuing the medication and after discarding other possible causes; this diagnosis was supported by the CIOMS/RUCAM scale, which showed a "likely" correlation between hepatocellular damage and drug toxicity etiology.
format Online
Article
Text
id pubmed-4002020
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Universidad del Valle
record_format MEDLINE/PubMed
spelling pubmed-40020202014-06-02 Albendazole-induced liver injury: a case report Ríos, David Restrepo, Juan C Colomb Med (Cali) Original Article We report a case of a 47-year-old male, who was referred to the clinical hepatology services at Pablo Tobón Uribe Hospital for evaluation of a jaundice syndrome. After undergoing several exams, we diagnosed hepatic hydatidosis and the patient was treated with albendazole; however, after five months of uninterrupted treatment the patient again consulted and his liver test showed marked hepatocellular damage. This time, the patient was diagnosed with drug-induced liver injury due to albendazole, based on information from the clinical record, history of drug consumption, clinical and laboratory tests improved after discontinuing the medication and after discarding other possible causes; this diagnosis was supported by the CIOMS/RUCAM scale, which showed a "likely" correlation between hepatocellular damage and drug toxicity etiology. Universidad del Valle 2013-06-30 /pmc/articles/PMC4002020/ /pubmed/24892458 Text en Copyright: © 2013 Universidad del Valle. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Ríos, David
Restrepo, Juan C
Albendazole-induced liver injury: a case report
title Albendazole-induced liver injury: a case report
title_full Albendazole-induced liver injury: a case report
title_fullStr Albendazole-induced liver injury: a case report
title_full_unstemmed Albendazole-induced liver injury: a case report
title_short Albendazole-induced liver injury: a case report
title_sort albendazole-induced liver injury: a case report
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002020/
https://www.ncbi.nlm.nih.gov/pubmed/24892458
work_keys_str_mv AT riosdavid albendazoleinducedliverinjuryacasereport
AT restrepojuanc albendazoleinducedliverinjuryacasereport